John Castellani, announced Tuesday as the new head of PhRMA, comes to PhRMA well-positioned for Washington in 2010, as something of a hedge depending on what happens in the November midterms — on good terms with the Obama White House, but also set up nicely in case Republicans take over the House of Representatives.
